Retour sur lavenir.net
   ACKERMANS V.HAAREN 284.800 € (-0,77 %)     AB INBEV 74.680 € (+1,22 %)     ARGENX SE 784.400 € (+0,33 %)     UMICORE 20.820 € (-2,25 %)     VASTNED 29.750 € (+0,34 %)     KBC ANCORA 80.900 € (+0,62 %)     IBA 16.760 € (+0,60 %)     KBC 117.250 € (-0,51 %)     ELIA GROUP 138.500 € (-0,86 %)     WDP 22.520 € (+1,08 %)     WHAT'S COOKING GP 144.500 € (0,00 %)     EVS 27.700 € (-0,72 %)     HOME INVEST BE. 19.300 € (-0,21 %)     AZELIS GROUP 9.910 € (-0,10 %)     SYENSQO 66.800 € (-0,30 %)     BPOST 1.552 € (-0,51 %)     TITAN S.A. 52.500 € (-1,50 %)     MELEXIS 76.400 € (-3,41 %)     GIMV 45.150 € (+2,03 %)     MONTEA 67.200 € (+1,66 %)     KINEPOLIS GROUP 36.500 € (+2,38 %)     SHURGARD 25.750 € (+0,98 %)     CENERGY 23.300 € (-3,80 %)     JENSEN-GROUP 84.200 € (+1,45 %)     ORANGE BELGIUM 21.500 € (0,00 %)     CIE BOIS SAUVAGE 302.000 € (0,00 %)     SIPEF 92.900 € (+0,32 %)     ATENOR 1.690 € (-3,43 %)     FAGRON 23.800 € (-0,63 %)     ACCENTIS 0.026 € (-1,89 %)     BEKAERT 39.500 € (-1,86 %)     FLUXYS BELGIUM D 19.500 € (+0,26 %)     RETAIL ESTATES 70.100 € (+0,43 %)     WERELDHAVE BELGIUM 52.800 € (+0,76 %)     XIOR 26.700 € (+1,14 %)     PROXIMUS 6.085 € (-0,33 %)     D'IETEREN GROUP 170.500 € (-1,73 %)     TINC 11.380 € (0,00 %)     SOFINA 220.200 € (+0,46 %)     ONWARD MEDICAL 2.640 € (+0,96 %)     ECONOCOM GROUP 1.515 € (+1,68 %)     GBL 78.950 € (-0,19 %)     RECTICEL 10.740 € (-1,10 %)     NYXOAH 1.530 € (+3,66 %)     AGEAS 69.750 € (+0,50 %)     CARE PROPERTY INV. 12.600 € (+0,48 %)     AGFA-GEVAERT 0.423 € (-1,40 %)     COFINIMMO 84.500 € (+1,62 %)     LOTUS BAKERIES 11 520.000 € (+0,88 %)     VIOHALCO 19.320 € (-0,92 %)     VGP 84.300 € (0,00 %)     BIOTALYS 3.120 € (-1,58 %)     TUBIZE-FIN 225.400 € (+2,55 %)     ONTEX GROUP 2.525 € (+0,20 %)     CMB.TECH 12.500 € (-4,87 %)     DECEUNINCK 2.220 € (0,00 %)     VAN DE VELDE 30.200 € (0,00 %)     CAMPINE 218.000 € (+1,87 %)     BREDERODE 104.600 € (+1,36 %)     CELYAD ONCOLOGY 0.251 € (+0,40 %)  
   NANOBIOTIX 31.080 € (+3,74 %)     SERGEFERRARI GROUP 8.000 € (+2,56 %)     TOTALENERGIES 68.360 € (-1,31 %)     SERGEFERRARI GROUP 8.000 € (+2,56 %)     ADYEN 824.900 € (+0,37 %)     EXAIL TECHNOLOGIES 116.700 € (+25,28 %)     SHELL PLC 33.700 € (-1,00 %)     BUREAU VERITAS 26.120 € (+0,66 %)     CAPGEMINI 89.680 € (+1,33 %)     HERMES INTL 1 626.000 € (+0,77 %)     PHILIPS KON 23.890 € (-0,17 %)     SANOFI 75.070 € (+1,78 %)     ASML HOLDING 1 578.200 € (-0,99 %)     BOLLORE 4.100 € (+0,15 %)     VEOLIA ENVIRON. 36.230 € (+0,22 %)     SMCP 5.015 € (+0,30 %)     FLOW TRADERS 25.580 € (-0,93 %)     ASM INTERNATIONAL 948.000 € (-4,34 %)     AYVENS 11.460 € (-0,87 %)     CSG 12.682 € (+2,69 %)     BE SEMICONDUCTOR 282.700 € (-2,21 %)     SCOR SE 31.980 € (+0,50 %)     STMICROELECTRONICS 62.580 € (-3,81 %)     ESSILORLUXOTTICA 168.650 € (+1,54 %)     CRCAM TOURAINE CCI 138.500 € (-0,93 %)     LISI 66.100 € (-0,15 %)     LVMH 495.750 € (+0,27 %)     BOUYGUES 49.750 € (-0,78 %)     DSM FIRMENICH AG 79.980 € (-0,65 %)     NEXANS 141.100 € (-3,75 %)     STELLANTIS NV 5.024 € (-1,95 %)     THALES 216.500 € (-0,87 %)     UMG 18.355 € (+0,71 %)     NN GROUP 76.320 € (-0,29 %)     AHOLD DEL 35.430 € (+0,85 %)     2CRSI 27.520 € (+8,01 %)     SOITEC 114.350 € (+1,87 %)     SODEXO 51.250 € (-0,10 %)     TKH GROUP 43.620 € (+1,73 %)     OVH 13.600 € (+1,49 %)     LNA SANTE 34.000 € (+3,03 %)     AMG 32.900 € (-1,56 %)     CEGEDIM 11.040 € (-1,43 %)     AALBERTS NV 38.980 € (-1,66 %)     EUROFINS SCIENT. 68.960 € (+1,00 %)     BAM GROEP KON 12.550 € (-1,18 %)     DANONE 72.120 € (+3,06 %)     ALSTOM 15.380 € (-1,94 %)     REXEL 36.860 € (-1,18 %)     RELX 27.440 € (-0,29 %)     HAFFNER ENERGY 0.217 € (-2,25 %)     ERAMET 45.160 € (-1,40 %)     SAINT GOBAIN 80.600 € (-1,42 %)     RUBIS 31.540 € (+0,64 %)     BNP PARIBAS ACT.A 101.120 € (-1,83 %)     JCDECAUX 19.050 € (+1,33 %)     PERNOD RICARD 65.960 € (-0,06 %)     SAVENCIA 66.600 € (0,00 %)     AIRBUS 191.900 € (-1,63 %)     ALTEN 53.400 € (+1,81 %)  
News Réglementées
11/01/2023 07:00

Cureus receives updated ESG risk rating from Sustainalytics and achieves even better, very low risk rating

EQS-News: Cureus GmbH / Key word(s): Real Estate/ESG
Cureus receives updated ESG risk rating from Sustainalytics and achieves even better, very low risk rating

11.01.2023 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Press release

Cureus receives updated ESG risk rating from Sustainalytics and achieves even better, very low risk rating

Hamburg, 11 January 2023. The rating, research and data company Sustainalytics has issued an updated rating for Cureus and has once again rated the risk of significant financial impacts from ESG factors to the company as low. Moreover, Cureus was able to significantly improve its rating.

Cureus is an integrated property company and portfolio holder that specialises in inpatient care properties. The company builds new properties for its own actively managed portfolio. In the updated rating, Cureus achieved an ESG Risk Rating of 10.1 points (previous year 12.2 points). The assessment, which is based on Sustainalytics’ proprietary 100-point ESG assessment criteria, covered the 2021 financial year. Cureus is thus at the lowest end of the “low risk” category having almost achieved a “negligible risk” rating. The acronym ESG stands for Environmental, Social and Governance, and the report was issued on 24 December 2022. Despite only being a couple of years old, Cureus ranked 63rd globally in the Real Estate category out of a total of 1,070 companies. In the sub-category Real Estate Management, Cureus improved from 17th place to 12th place out of a total of 157 companies evaluated worldwide.

With the rating from Sustainalytics, Cureus underlines its commitment to transparently documenting the fulfilment of sustainability criteria in its business activities. In the summer of 2022, the company also published its second sustainability report on the 2021 financial year (Download here).

Gerald Klinck, CEO of Cureus: “We are delighted that the independent experts from Sustainalytics have once again issued an extremely positive assessment of our risk profile, especially as the risks Cureus was exposed to since the last analysts’ rating in 2021 actually increased slightly compared to the previous year. Our internal efforts in managing ESG risks, for example through clear processes, comprehensive guidelines and relevant training, combined with extended data transparency in reporting energy and resource consumption in our properties and on our construction sites, have led to a further reduction in risk and this excellent result. We take this success as an incentive not to stand still, but to continue to develop our ESG strategies, both internally and externally”.

The ESG Risk Rating from Sustainalytics provides clear insights into ESG risk at company level by measuring the extent of an organisation’s unmanaged ESG risk. To do this, the ESG performance of more than 15,600 companies is assessed on a risk scale from negligible to severe. The ESG Risk Rating of all assessed companies can be viewed here filtered by sector: https://www.sustainalytics.com/esg-rating.

 

Images & Downloads

 Photo Gerald Klinck (CEO), Cureus
…Download here…
Copyright: Heribert Schindler
 Responsibility and Transparency – Sustainability Report 2021
…Download here…

 

Press contact

Christoph Wilhelm
Corporate Communication

Cureus GmbH
T +49 171 56 86 575
E cw@cureus.de
W www.cureus.de

 

About Cureus GmbH

Cureus GmbH has its operational headquarters in Hamburg and, with more than 15 years of experience and a team of around 160 employees, is an experienced integrated property company with special expertise in care homes in Germany that develops and manages its own property portfolio actively.

With its “system care home” standard, Cureus has developed a unique standard for care homes for inpatient care and assisted living, which can be implemented as a scalable solution independent of location. Based on the current legal requirements as well as the needs of operators, residents, and communities, Cureus is establishing new, consistent quality standards with its system care homes. The company is thereby offering a highly efficient product, which combines higher cost-efficiency at lower cost structures with improved living and service quality in the care sector.

With an average age of four years, the company’s property portfolio is still relatively new and, as of 30 September 2022, consists of 51 properties on long-term leases to care home operators with 5,071 care places and 278 assisted living units worth around EUR 1 billion. In addition, the company has 38 projects currently under construction and 62 notarised projects, which will add a further 7,740 care places and around 1,830 assisted living units to the portfolio by 2026. These projects have an expected value after completion of around EUR 2 billion. www.cureus.de/en

Copyright© 2022 Sustainalytics. All rights reserved. This release contains information developed by Sustainalytics. Such information and data are proprietary of Sustainalytics and/or its third party suppliers (Third Party Data) and are provided for informational purposes only. They do not constitute an endorsement of any product or project, nor an investment advice and are not warranted to be complete, timely, accurate or suitable for a particular purpose. Their use is subject to conditions available here.



11.01.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1531601  11.01.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1531601&application_name=news&site_id=symex

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière